CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | Trigilio Jeffrey Chief Financial Officer | Sale | −399 | $8.76 | $3K | 86,541 |
| 2023-05-12 | Michaelson Jennifer Chief Development Officer | Sale | −193 | $8.78 | $2K | 90,686 |
| 2023-05-12 | Trigilio Jeffrey Chief Financial Officer | Sale | −347 | $8.78 | $3K | 86,940 |
| 2023-04-25 | AHMED NADIM President and CEO | Sale | −716 | $10.59 | $8K | 117,288 |
| 2023-04-18 | Jones Jeffrey Alan Chief Medical Officer | Sale | −392 | $10.71 | $4K | 59,218 |
| 2023-04-18 | Trigilio Jeffrey Chief Financial Officer | Sale | −398 | $10.71 | $4K | 87,287 |
| 2023-04-18 | Michaelson Jennifer Chief Development Officer | Sale | −238 | $10.71 | $3K | 90,879 |
| 2023-04-18 | SUMER JACQUELYN L Chief Legal Officer | Sale | −290 | $10.71 | $3K | 46,405 |
| 2023-04-12 | Trigilio Jeffrey Chief Financial Officer | Sale | −318 | $10.22 | $3K | 87,685 |
| 2023-04-12 | Michaelson Jennifer Chief Development Officer | Sale | −176 | $10.22 | $2K | 91,117 |
| 2023-03-23 | AHMED NADIM President and CEO | Sale | −706 | $10.51 | $7K | 118,004 |
| 2023-03-20 | Trigilio Jeffrey Chief Financial Officer | Sale | −399 | $11.32 | $5K | 88,003 |
| 2023-03-20 | Jones Jeffrey Alan Chief Medical Officer | Sale | −390 | $11.32 | $4K | 59,610 |
| 2023-03-20 | Michaelson Jennifer Chief Development Officer | Sale | −238 | $11.32 | $3K | 91,293 |
| 2023-03-20 | SUMER JACQUELYN L Chief Legal Officer | Sale | −305 | $11.32 | $3K | 46,695 |
| 2023-02-22 | AHMED NADIM President and CEO | Grant or award | +109,000 | 118,710 | ||
| 2023-02-22 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +211,000 | 211,000 | ||
| 2023-02-17 | Trigilio Jeffrey Chief Financial Officer | Grant or award | +47,000 | 88,402 | ||
| 2023-02-17 | Trigilio Jeffrey Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +93,500 | 93,500 | ||
| 2023-02-17 | Savill Corrine Chief Business Officer | Grant or award | +20,500 | 170,115 |
Page 10 of 23 · 446 trades